BioCentury
ARTICLE | Product Development

Opportunity in Crisis

May 4, 2009 7:00 AM UTC

The scramble to create and mass produce vaccines to combat the outbreak of H1N1 swine influenza is exposing the limitations of global pandemic preparedness and, in the process, highlighting scientific, technological and commercial opportunities for a more robust public health response to the threat of pandemic influenza.

The biggest opportunities involve intensified development of novel adjuvants and of innovative manufacturing methods that move beyond 60-year-old production processes that grow vaccines in chicken eggs...